Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01814410 · ClinicalTrials.gov registry record · Early Phase 1
Interactive Effects of IV Ethanol and IV Nicotine
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT01814410 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 5 participants.
The verdict
NCT01814410, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
There are mixed reports on nicotine's effects on ethanol-induced impairment in cognitive performance and behavior in humans. The main objective of this study is to characterize the interactive effects of acute intravenous (IV) ethanol and nicotine administration on cognition and behavior in healthy smokers. The general hypothesis is that nicotine will attenuate the negative effects of ethanol on cognition and subjective stimulant/sedative effects of ethanol.
Interventions
- DRUG Intravenous ethanol placebo plus nicotine infusions
- DRUG intravenous ethanol 40mg% plus nicotine infusions
- DRUG intravenous ethanol 100mg% plus nicotine infusions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-02-22 |
| Est. Completion | 2014-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01814410
The ClinicalTrials.gov registry entry for NCT01814410 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Intravenous ethanol placebo plus nicotine infusions is the first listed.
NCT01814410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01814410 about?
NCT01814410 is a clinical study titled "Interactive Effects of IV Ethanol and IV Nicotine". There are mixed reports on nicotine's effects on ethanol-induced impairment in cognitive performance and behavior in humans. The main objective of this study is to characterize the interactive effects of acute intravenous (IV) ethanol and nicotine administration on cognition and behavior in healthy ...
What is the current status of trial NCT01814410?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2013-02-22. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01814410?
The interventions under investigation include: Intravenous ethanol placebo plus nicotine infusions (DRUG), intravenous ethanol 40mg% plus nicotine infusions (DRUG), intravenous ethanol 100mg% plus nicotine infusions (DRUG).
Who is sponsoring clinical trial NCT01814410?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.